Drug lookup
Drug reference

bremelanotide

Melanocortin Receptor Agonist · Sexual Dysfunction Agent

Melanocortin Receptor AgonistSexual Dysfunction Agent
CDSCO approved
EXCRETION
not curated
INTERACTIONS
1 major
SEVERE in our sources
PREGNANCY
not curated
Top interactions
  • NaltrexoneSevereDatabaseDDInter

Mechanism

Bremelanotide activates melanocortin receptors; the mechanism by which it improves sexual desire and related distress is unknown.

Indications

generalized hypoactive sexual desire disorder (HSDD) in premenopausal women

Dosing

Adult
self-administered injection 45 min prior to anticipated sexual activity

Contraindications

  • women at high risk for cardiovascular disease

Side effects

Common
nauseaincreased blood pressure

Drug interactions

Naltrexone
Severe
Database

Drug interaction classified as: absorption

Source: DDInter

Related guidelines

Ask House about bremelanotide

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team